Renasant (RNST) Q2 2026 earnings review
Profitability Stabilizes, But Core Deposit Leaks Emerge
Renasant delivered a steady Q2 with EPS flat at $0.94 and net income stable at $87.1 million. The headline positive is a reversal in loan growth—loans grew at a 4.7% annualized rate ($220.9 million), breaking Q1's contraction. However, earnings quality is mixed. The loan growth was heavily subsidized by a $58.3 million portfolio acquisition by its Republic Business Credit subsidiary. On the funding side, deposits contracted by $398.4 million. While management blamed seasonal public fund outflows, a $145.4 million drop in noninterest-bearing core deposits is a red flag. Management is flexing its strong 16.25% ROTCE by aggressively buying back stock ($60 million repurchased), signaling confidence, but expense creep and deposit attrition require immediate monitoring.
🐂 Bull Case
Management is aggressively optimizing its capital stack. Q2 saw $60 million in share repurchases at $39.54, up from virtually zero in prior quarters, and the board expanded the authorization to $250 million. A $300 million sub-debt offering in May provides ample dry powder.
Despite macro concerns in the broader regional banking sector, Renasant's credit metrics are actually improving. Nonperforming loans dropped from 1.06% to 0.97% of total loans, and criticized loans fell 11 basis points to 2.66%.
🐻 Bear Case
The post-merger efficiency narrative took a hit. Noninterest expenses grew $6.2 million QoQ due to deferred comp and health claims, driving the adjusted efficiency ratio up to 54.92% from 52.82%.
While total deposits fell $398.4 million (largely cited as seasonal public funds), noninterest-bearing deposits fell $145.4 million QoQ. Funding loans with higher-cost debt rather than free deposits will eventually compress margins.
⚖️ Verdict: ⚪
Neutral. Profitability and credit are rock solid, and aggressive buybacks provide a floor. But to earn a premium valuation, the company must prove it can generate organic loan growth without inorganic bolt-ons, while plugging the core deposit leak.
Key Themes
Loan Growth Rebounds, Aided by Inorganic Bolt-On
After a disappointing Q1 loan contraction of $16 million, Q2 saw a reversing trend with total loans growing by $220.9 million (4.7% annualized). However, over a quarter of this growth ($58.3 million) came from a portfolio acquisition by Renasant's Republic Business Credit subsidiary. Excluding this, organic loan growth was roughly $162.6 million (3.4% annualized). Commercial and Industrial (C&I) and Commercial Real Estate (CRE) drove the advances.
Aggressive Capital Returns Provide Floor
Capital optimization is accelerating. After a period of integrating The First Bancshares, Renasant turned on the buyback machine in Q2, repurchasing $60 million in stock at an average price of $39.54. Furthermore, the board authorized an additional $100 million to the repurchase plan (now $250 million total), leaving $101.8 million available. Supported by a 16.25% ROTCE, this aggressively defends the stock price and boosts EPS.
Asset Quality Remains Pristine
Credit fears are not materializing. Nonperforming loans (NPLs) decreased from $200.3 million in Q1 to $186.5 million in Q2, representing 0.97% of total loans (down from 1.06%). Criticized loans also fell sequentially. Net charge-offs remained negligible at $2.8 million, or just 0.06% annualized. The allowance for credit losses (ACL) remains robust at 158.7% of nonperforming loans.
Core Deposit Leakage Contradicts Seasonal Narrative
Management attributed the $398.4 million linked-quarter deposit decline to a $367.7 million seasonal outflow of public funds. But this masks a deeper problem: noninterest-bearing deposits contracted by $145.4 million in Q2. Noninterest-bearing deposits now represent 23.2% of the mix, down from 23.5% in Q1. This signals structural deposit attrition beyond just municipal seasonality, forcing reliance on higher-cost funding.
Expense Creep Stalls Efficiency Narrative
The company's adjusted efficiency ratio took a step backward, decelerating from an impressive 52.82% in Q1 to 54.92% in Q2. Noninterest expenses increased $6.2 million QoQ to $161.5 million. Management blamed deferred compensation accruals tied to market valuations, higher health insurance claims, and annual merit increases. If this elevated run-rate holds, it undermines the operating leverage narrative established post-merger.
Macro Margin Squeeze Persists
While Adjusted Net Interest Margin (NIM) remained perfectly stable at 3.61%, the underlying mechanics reveal macro pressure. The adjusted loan yield decelerated by 1 basis point to 6.03%, while the cost of total deposits accelerated by 2 basis points to 1.96%. The bank is unable to pass higher funding costs onto borrowers, making future margin expansion highly reliant on Federal Reserve rate cuts.
Other KPIs
Stable. Down a negligible $0.8 million linked quarter. Adjusted NII (FTE) was $214.5 million, up $1.2 million QoQ. The stability in NII proves that the balance sheet is well-hedged against current rate volatility, but lacks an immediate catalyst for expansion.
Stable. Increased $0.9 million linked quarter. Strength in wealth management ($9.1 million, up QoQ) and higher BOLI income offset a slight $0.3 million dip in mortgage banking income. Mortgage lock volume rose nicely to $611.6 million, but gain on sale margins compressed heavily from 1.85% to 1.57%.
Accelerating. Up 1.4% linked quarter from $25.00, driven by retained earnings and accretive share repurchases, partially offset by a $9.2 million negative fair market value adjustment in the available-for-sale securities portfolio.
Key Questions
Organic vs. Inorganic Growth
With the Republic Business Credit portfolio accounting for over a quarter of Q2's loan growth, what is the true underlying organic growth rate of the legacy bank, and are further bolt-on acquisitions planned for the second half of the year?
Core Deposit Stabilization
Beyond the seasonal public fund outflows, noninterest-bearing deposits fell by over $145 million. Is this a temporary fluctuation, or are commercial clients actively migrating funds to higher-yielding alternatives?
Expense Run-Rate
Noninterest expense jumped $6.2 million sequentially due to merit, healthcare, and deferred comp. Should we consider the $161.5 million figure the new baseline run-rate going forward, or are some of these items strictly Q2 anomalies?